Results 201 to 210 of about 108,296 (239)

Differences in Anti-αvβ6 Integrin Antibody Expression between U.S. and Japanese Cohorts in Inflammatory Bowel Disease. [PDF]

Inflamm Bowel Dis
Kakuta Y, Li D, Debbas P, Okazaki S, Sawahashi M, Yang S, Iwaki H, Okamoto D, Nagai H, Shimoyama Y, Naito T, Moroi R, Kuroha M, Shiga H, Kinouchi Y, Shirai T, Fujii H, McGovern DPB, Masamune A.   +18 more
europepmc   +1 more source

A Population‐Based Matched Cohort Study of Extra‐Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy, Faria Ahmed, Michael Pugliese, Monica Taljaard, Parul Tandon, Priscilla Matthews, Gilaad G. Kaplan, Stephanie Coward, Charles N. Bernstein, Eric I. Benchimol, M. Ellen Kuenzig, Laura E. Targownik, Harminder Singh, on behalf of the Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC)   +13 more
wiley   +1 more source

Diagnostic accuracy of anti-integrin αvβ6 in ulcerative colitis: a diagnostic meta-analysis. [PDF]

J Gastroenterol
Nisar M, Awan AR, Ahmad A, Saleem H, Ayyazuddin M, Javed R, Khan AR, Nadeem MA, Malik MA, Sohail AH, Sheikh AB.   +10 more
europepmc   +1 more source

The effect of proton-pump inhibitor therapy on disease outcomes in inflammatory bowel disease: a population-based cohort study. [PDF]

Therap Adv Gastroenterol
Deleuran T, Juul Poulsen G, Larsen L, Fallingborg J, Jepsen P, Jess T.   +5 more
europepmc   +1 more source

Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission. [PDF]

Cureus
Farhad ME, Belal I, Baana M, Childs C, Al-Rufayie M.   +4 more
europepmc   +1 more source

NCF2 as a Novel Diagnostic Biomarker in Ulcerative Colitis: Linking Macrophage Infiltration to Immune Dysregulation via Multi-Omics Analysis. [PDF]

J Inflamm Res
Zhang F, Zhu J, Liu H, Ye J, Li Y, Wang B.   +5 more
europepmc   +1 more source

Correction to: "Management of ulcerative colitis by dichloroacetate: impact on NFATC1/NLRP3/IL1B signaling based on bioinformatics analysis combined with in vivo experimental verification" [Inflammopharmacology (2024) 32:667-682]. [PDF]

Inflammopharmacology
Abdel-Razek E, Mahmoud HM, Azouz AA.
europepmc   +1 more source

Therapeutic Potential of <i>Beaucarnea recurvata</i> Leaf Extract Against Ulcerative Colitis: Integrating Phytochemical Profiling, Network Pharmacology, and Experimental Validation. [PDF]

Int J Mol Sci
Tawfeek N, Orfali R, Perveen S, Ghafar S, Fikry E, Elbatreek MH, Elbaramawi SS, El-Domiaty MM, El-Shafae AM.   +8 more
europepmc   +1 more source